Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.80B | 2.54B | 3.32B | 3.29B | 2.77B | 2.00B |
Gross Profit | 638.53M | 482.13M | 890.96M | 961.32M | 669.15M | 532.60M |
EBITDA | 263.58M | -319.47M | 519.64M | 570.27M | 358.40M | 280.63M |
Net Income | 55.63M | -399.67M | 208.29M | 254.48M | 182.88M | 179.45M |
Balance Sheet | ||||||
Total Assets | 3.55B | 2.88B | 3.78B | 3.98B | 3.83B | 2.05B |
Cash, Cash Equivalents and Short-Term Investments | 1.63B | 1.41B | 1.70B | 2.04B | 1.66B | 1.57B |
Total Debt | 696.00M | 652.00M | 696.00M | 840.00M | 984.00M | 130.80M |
Total Liabilities | 916.00M | 870.85M | 1.10B | 1.35B | 1.48B | 415.28M |
Stockholders Equity | 2.08B | 1.67B | 2.13B | 2.10B | 1.84B | 1.64B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 62.34M | 37.39M | 560.78M | 178.99M | 180.64M |
Operating Cash Flow | 0.00 | 74.80M | 186.54M | 652.49M | 234.18M | 229.83M |
Investing Cash Flow | 0.00 | -143.60M | -207.72M | -129.35M | -1.02B | -94.41M |
Financing Cash Flow | 0.00 | -225.59M | -321.88M | -136.17M | 872.27M | 917.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥1.70B | 9.03 | 5.75% | 9.24% | -23.24% | ||
79 Outperform | ¥3.13B | 18.54 | ― | 15.67% | -18.07% | ||
78 Outperform | ¥2.71B | 15.59 | ― | 18.94% | 61.02% | ||
64 Neutral | kr60.89B | 13.58 | 1.88% | 7.60% | 0.71% | -4.20% | |
59 Neutral | ¥2.24B | 52.02 | 2.72% | -7.85% | -89.50% | ||
53 Neutral | ¥2.05B | ― | ― | 7.11% | -222.15% | ||
52 Neutral | ¥2.12B | 37.42 | ― | -23.31% | -309.90% |